Quale sarebbe il prezzo per TMS Co., Ltd. (4891)

Il prezzo per TMS Co., Ltd. (4891) è $0.72420509

Qual è la capitalizzazione di mercato per TMS Co., Ltd. (4891)

La capitalizzazione di mercato per TMS Co., Ltd. (4891) è $33.00M

TMS Co., Ltd. (4891) Prezzo e Capitalizzazione di Mercato

Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.

Il prezzo per 4891	Attivo B	Capitalizzazione del mercato a B	Risultati
$116,327 $33.00M	NVDA	$5.301T	+16,062,602.78%
$101,690 $33.00M	AAPL	$4.634T	+14,041,458.10%
$90,917.22 $33.00M	GOOG	$4.143T	+12,553,970.25%
$78,768.35 $33.00M	MSFT	$3.589T	+10,876,425.87%
$62,695.39 $33.00M	AMZN	$2.857T	+8,657,032.55%

Il prezzo per 4891

Attivo B

Capitalizzazione del mercato a B

Risultati

$116,327 $33.00M